课题基金 / 基金详情

Immunoregulation in CNS remyelination

Immunoregulation in CNS remyelination
中枢神经系统髓鞘再生中的免疫调节
批准号:
10432140
负责人:
Jeffrey K Huang
金额:
$34.02万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-01 至 2024-05-31

项目摘要

项目成果

Jeffrey K Huang的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 多发性硬化症(MS)髓鞘再生失败导致进行性轴突丢失 和累积的残疾。我们先前已经发现,白介素4诱导了一种(IL4I1), 一种巨噬细胞分泌的免疫调节酶,用于分解L的氨基酸, 调节炎症以促进小鼠中枢神经系统(CNS)的重新髓鞘形成。 此外,我们还发现,IL4i1通过减少促炎的CD4+Th1来促进髓鞘再生 中枢神经系统病变的Th17细胞活性。IL4i1究竟是如何在病变中发挥作用的 髓鞘再分化过程中的微环境尚不清楚。但是,中对IL4i1的要求 重新髓鞘形成表明了一种以前未知的涉及氨基酸代谢的机制 在中枢神经系统损伤中发挥作用,控制炎症,促进修复。在这里,我们假设 中枢神经系统损伤中氨基酸代谢的调节是髓鞘再生成功的关键。至 为此,我们将分析中枢神经系统损伤过程中的氨基酸水平。 通过质谱分析重新髓鞘形成(目标1),确定氨基酸转运是否 调节炎症和重新髓鞘形成所需的(目标2),并确定 氨基酸代谢影响再髓鞘形成效率(目标3)。这项研究的结果,如果 成功,将阐明氨基酸代谢在中枢神经系统免疫细胞中的作用 重新髓鞘形成,并导致未来对氨基酸代谢调节剂的潜在研究 改善多发性硬化髓鞘再生的治疗方法
英文摘要
Project Summary Failure to regenerate myelin in multiple sclerosis (MS) contributes to progressive axonal loss and accumulated disability. We have previously found that interleukin-four induced one (IL4i1), a macrophage-secreted immunoregulatory enzyme that serves to breakdown L-amino acids, modulates inflammation to promote remyelination in the mouse central nervous system (CNS). Moreover, we found that IL4i1 promotes remyelination by reducing pro-inflammatory CD4+ Th1 and Th17 cell activity in CNS lesions. Exactly how IL4i1 exerts its effect on the lesion microenvironment during remyelination remains unknown. However, the requirement for IL4i1 in remyelination suggests that a previously unknown mechanism involving amino acid metabolism operates in CNS lesions to control inflammation and promote repair. Here, we hypothesize that the regulation of amino acid metabolism in CNS lesions is critical for remyelination success. To this end, we will profile the levels of amino acids in CNS lesions over the course of remyelination by mass spectrometry analysis (Aim 1), determine if amino acid transport is required to regulate inflammation and remyelination (Aim 2), and determine if modulators of amino acid metabolism affects remyelination efficiency (Aim 3). The results of this study, if successful, will elucidate the role of amino acid metabolism on immune cells in CNS remyelination, and lead to future studies on modulators of amino acid metabolism as potential therapeutics for improving remyelination in MS.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Acute motor deficit and subsequent remyelination-associated recovery following internal capsule demyelination in mice.
小鼠内囊脱髓鞘后,急性运动不足以及随后与透明度相关的恢复。
DOI: 10.1111/jnc.15142
发表时间: 2021-03
期刊: Journal of neurochemistry
影响因子: 4.7
作者: [Yamazaki R, Ohno N, Huang JK]
通讯作者: Huang JK
DOI: 10.1038/s41598-021-96395-4
发表时间: 2021-08-19
期刊: Scientific reports
影响因子: 4.6
作者: [Yamazaki R, Osanai Y, Kouki T, Shinohara Y, Huang JK, Ohno N]
通讯作者: Ohno N
Analysis of mouse models of premature glial senescence
  • 批准号:
    10554278
  • 项目类别:
  • 资助金额:
    $19.5万
  • 财政年份:
    2022
  • 负责人:
    Jeffrey K Huang
  • 依托单位:
Analysis of mouse models of premature glial senescence
  • 批准号:
    10373179
  • 项目类别:
  • 资助金额:
    $23.4万
  • 财政年份:
    2022
  • 负责人:
    Jeffrey K Huang
  • 依托单位:
Immunoregulation in CNS remyelination
  • 批准号:
    9926930
  • 项目类别:
  • 资助金额:
    $34.02万
  • 财政年份:
    2018
  • 负责人:
    Jeffrey K Huang
  • 依托单位:
海外基金